Related Experiment Videos

Associations between urinary dialkyl phosphate metabolites and cardiometabolic and kidney outcomes in U.S. children

Mahie Mozib Abdullah1, Liam Connolly1, Rachel Frank1

  • 1Cohen Children's Medical Center, Queens, NY, United States; Northwell Health, New Hyde Park, NY, United States.

Insights

Organophosphate pesticide exposure, measured by urinary dialkyl phosphate (DAP) metabolites, is linked to kidney issues like microalbuminuria and hyperfiltration in children. These findings suggest potential early-life kidney effects from pesticide exposure.

Area of Science:

  • Environmental Health
  • Pediatric Nephrology
  • Toxicology

Background:

  • Organophosphate pesticide exposure is linked to adult cardiometabolic and kidney disorders.
  • The impact of pesticide exposure on children's kidney and cardiovascular health is not well understood.
  • Urinary dialkyl phosphates (DAP) are biomarkers of organophosphate pesticide exposure.

Purpose of the Study:

  • To evaluate the association between urinary DAP metabolite concentrations and early markers of kidney and cardiovascular stress in children.
  • To investigate potential links between specific DAP metabolites and conditions like microalbuminuria and kidney hyperfiltration.

Main Methods:

  • Analysis of a nationwide sample of 2928 children from the 2015-2020 National Health and Nutrition Examination Survey (NHANES).
  • Measurement of six urinary DAP metabolites (DMP, DEP, DMTP, DETP, DMDTP, DEDTP).
  • Assessment of clinical outcomes including blood pressure indices, hypertensive status, microalbuminuria, and kidney hyperfiltration using multivariate regression models adjusted for covariates.

Main Results:

  • Higher concentrations of diethyldithiophosphate (DEDTP) were significantly associated with both microalbuminuria (OR 1.290) and kidney hyperfiltration (OR 2.348).
  • Higher concentrations of dimethyldithiophosphate (DMDTP) were significantly associated with kidney hyperfiltration (OR 1.466).
  • No significant associations were found between DAP metabolites and blood pressure indices or hypertensive status.

Conclusions:

  • Elevated urinary concentrations of specific DAP metabolites, particularly DEDTP and DMDTP, are associated with microalbuminuria and kidney hyperfiltration in U.S. children.
  • These findings suggest potential kidney effects from early-life organophosphate pesticide exposure.
  • Further research is warranted to elucidate the underlying mechanisms of these associations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...